Luck A - Search Results

1

Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA.

Rozaklis T, Beard H, Hassiotis S, Garcia AR, Tonini M, Luck A, Pan J, Lamsa JC, Hopwood JJ, Hemsley KM. Rozaklis T, et al. Among authors: luck a. Exp Neurol. 2011 Jul;230(1):123-30. doi: 10.1016/j.expneurol.2011.04.004. Epub 2011 Apr 16. Exp Neurol. 2011. PMID: 21515264

2

Examination of intravenous and intra-CSF protein delivery for treatment of neurological disease.

Hemsley KM, Luck AJ, Crawley AC, Hassiotis S, Beard H, King B, Rozek T, Rozaklis T, Fuller M, Hopwood JJ. Hemsley KM, et al. Eur J Neurosci. 2009 Mar;29(6):1197-214. doi: 10.1111/j.1460-9568.2009.06666.x. Eur J Neurosci. 2009. PMID: 19302155

3

Helper-dependent canine adenovirus vector-mediated transgene expression in a neurodegenerative lysosomal storage disorder.

Lau AA, Rozaklis T, Ibanes S, Luck AJ, Beard H, Hassiotis S, Mazouni K, Hopwood JJ, Kremer EJ, Hemsley KM. Lau AA, et al. Among authors: luck aj. Gene. 2012 Jan 1;491(1):53-7. doi: 10.1016/j.gene.2011.09.004. Epub 2011 Sep 22. Gene. 2012. PMID: 21963444

4

Determination of the role of injection site on the efficacy of intra-CSF enzyme replacement therapy in MPS IIIA mice.

Beard H, Luck AJ, Hassiotis S, King B, Trim PJ, Snel MF, Hopwood JJ, Hemsley KM. Beard H, et al. Mol Genet Metab. 2015 May;115(1):33-40. doi: 10.1016/j.ymgme.2015.03.002. Epub 2015 Mar 12. Mol Genet Metab. 2015. PMID: 25795516

5

Continual Low-Dose Infusion of Sulfamidase Is Superior to Intermittent High-Dose Delivery in Ameliorating Neuropathology in the MPS IIIA Mouse Brain.

Beard H, Hassiotis S, Luck AJ, Rozaklis T, Hopwood JJ, Hemsley KM. Beard H, et al. JIMD Rep. 2016;29:59-68. doi: 10.1007/8904_2015_495. Epub 2015 Dec 1. JIMD Rep. 2016. PMID: 26620043 Free PMC article.

6

A Preclinical Study Evaluating AAVrh10-Based Gene Therapy for Sanfilippo Syndrome.

Winner LK, Beard H, Hassiotis S, Lau AA, Luck AJ, Hopwood JJ, Hemsley KM. Winner LK, et al. Among authors: luck aj. Hum Gene Ther. 2016 May;27(5):363-75. doi: 10.1089/hum.2015.170. Hum Gene Ther. 2016. PMID: 26975339

7

Disease stage determines the efficacy of treatment of a paediatric neurodegenerative disease.

Hassiotis S, Beard H, Luck A, Trim PJ, King B, Snel MF, Hopwood JJ, Hemsley KM. Hassiotis S, et al. Among authors: luck a. Eur J Neurosci. 2014 Jun;39(12):2139-50. doi: 10.1111/ejn.12557. Eur J Neurosci. 2014. PMID: 25068161

8

Preclinical evaluation of DC-CIK cells as potentially effective immunotherapy model for the treatment of glioblastoma.

Lück AS, Pu J, Melhem A, Schneider M, Sharma A, Schmidt-Wolf IGH, Maciaczyk J. Lück AS, et al. Sci Rep. 2025 Jan 3;15(1):734. doi: 10.1038/s41598-024-84284-5. Sci Rep. 2025. PMID: 39753685 Free PMC article.

9

Combination treatment with histone deacetylase and carbonic anhydrase 9 inhibitors shows therapeutic potential in experimental diffuse intrinsic pontine glioma.

Fujita N, Bondoc A, Simoes S, Ishida J, Taccone MS, Luck A, Srikanthan D, Siddaway R, Levine A, Sabha N, Krumholtz S, Kondo A, Arai H, Smith C, McDonald P, Hawkins C, Dedhar S, Rutka J. Fujita N, et al. Among authors: luck a. Brain Tumor Pathol. 2024 Oct;41(3-4):117-131. doi: 10.1007/s10014-024-00493-w. Epub 2024 Sep 24. Brain Tumor Pathol. 2024. PMID: 39316272

10

The Distribution of Carceral Harm: County-Level Jail Incarceration and Mortality by Race, Sex, and Age.

Luck AN. Luck AN. Demography. 2024 Oct 1;61(5):1455-1482. doi: 10.1215/00703370-11555025. Demography. 2024. PMID: 39259052

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters